Area of research
Public Health, Environmental and Occupational Health · Immunology
Research interest
Research focused on Immunotherapy and Bridge (graph theory), with related work in Melanoma, Mutation, Chemotherapy. Notable publications include 'The Ubiquitin Ligase FBXW7 Modulates Leukemia-Initiating Cell Activity by Regulating MYC Stability', 'Activating mutations in the NT5C2 nucleotidase gene drive chemotherapy resistance in relapsed ALL', and 'Direct Reversal of Glucocorticoid Resistance by AKT Inhibition in Acute Lymphoblastic Leukemia'.
Immunotherapy Bridge 2017 and Melanoma Bridge 2017: meeting abstracts
Immunotherapy Bridge 2016 and Melanoma Bridge 2016: meeting abstracts
Mutational landscape, clonal evolution patterns, and role of RAS mutations in relapsed acute lymphoblastic leukemia
Constitutive LcK activity drives sensitivity differences between CD8+ memory T cell subsets
Melanoma expression of matrix metalloproteinase-23 is associated with blunted tumor immunity and poor responses to immunotherapy
The Ubiquitin Ligase FBXW7 Modulates Leukemia-Initiating Cell Activity by Regulating MYC Stability
Activating mutations in the NT5C2 nucleotidase gene drive chemotherapy resistance in relapsed ALL
Direct Reversal of Glucocorticoid Resistance by AKT Inhibition in Acute Lymphoblastic Leukemia
Genetic loss of SH2B3 in acute lymphoblastic leukemia
Reverse engineering of TLX oncogenic transcriptional networks identifies RUNX1 as tumor suppressor in T-ALL